Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariantonietta D'Ambrosio

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Developmental Cell|June 20, 2023
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapiesMariantonietta D'Ambrosio, Jesús Gil
Cell Metabolism|April 8, 2026
Polyunsaturated lipids kill senescent cells by ferroptosisMariantonietta D'Ambrosio, Jesús Gil
Nature Communications|April 22, 2022
Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancerMartina Troiani, Manuel Colucci, Mariantonietta D'Ambrosio, et al.
Iscience|August 10, 2023
Genetic ablation of ketohexokinase C isoform impairs pancreatic cancer developmentIlaria Guccini, Guanghui Tang, Trang Thuy To, et al.
Cancer Cell|November 13, 2020
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer MetastasisIlaria Guccini, Ajinkya Revandkar, Mariantonietta D'Ambrosio, et al.
Science Advances|January 15, 2025
SMARCA4 regulates the NK-mediated killing of senescent cellsVirinder Reen, Mariantonietta D'Ambrosio, Pia Pernille Søgaard, et al.
Cancer Cell|March 3, 2023
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancerNicolò Bancaro, Bianca Calì, Martina Troiani, et al.
Cancer Cell|March 1, 2024
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cellsManuel Colucci, Sara Zumerle, Silvia Bressan, et al.
Nature Cell Biology|April 24, 2026
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerabilityMariantonietta D'Ambrosio, Matthew E H White, Efthymios S Gavriil, et al.
The Journal of Clinical Investigation|April 7, 2020
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivoAbdullah Alajati, Mariantonietta D'Ambrosio, Martina Troiani, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Developmental Cell|June 20, 2023
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapiesMariantonietta D'Ambrosio, Jesús Gil
Cell Metabolism|April 8, 2026
Polyunsaturated lipids kill senescent cells by ferroptosisMariantonietta D'Ambrosio, Jesús Gil
Nature Communications|April 22, 2022
Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancerMartina Troiani, Manuel Colucci, Mariantonietta D'Ambrosio, et al.
Iscience|August 10, 2023
Genetic ablation of ketohexokinase C isoform impairs pancreatic cancer developmentIlaria Guccini, Guanghui Tang, Trang Thuy To, et al.
Cancer Cell|November 13, 2020
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer MetastasisIlaria Guccini, Ajinkya Revandkar, Mariantonietta D'Ambrosio, et al.
Science Advances|January 15, 2025
SMARCA4 regulates the NK-mediated killing of senescent cellsVirinder Reen, Mariantonietta D'Ambrosio, Pia Pernille Søgaard, et al.
Cancer Cell|March 3, 2023
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancerNicolò Bancaro, Bianca Calì, Martina Troiani, et al.
Cancer Cell|March 1, 2024
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cellsManuel Colucci, Sara Zumerle, Silvia Bressan, et al.
Nature Cell Biology|April 24, 2026
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerabilityMariantonietta D'Ambrosio, Matthew E H White, Efthymios S Gavriil, et al.
The Journal of Clinical Investigation|April 7, 2020
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivoAbdullah Alajati, Mariantonietta D'Ambrosio, Martina Troiani, et al.
Pageof 2